241 related articles for article (PubMed ID: 25244566)
1. Factors associated with persistence of red blood cell antibodies in woman after pregnancies complicated by fetal alloimmune haemolytic disease treated with intrauterine transfusions.
Verduin EP; Brand A; van de Watering LM; Claas FH; Oepkes D; Lopriore E; Doxiadis II; Schonewille H
Br J Haematol; 2015 Feb; 168(3):443-51. PubMed ID: 25244566
[TBL] [Abstract][Full Text] [Related]
2. High anti-HLA response in women exposed to intrauterine transfusions for severe alloimmune hemolytic disease is associated with mother-child HLA triplet mismatches, high anti-D titer, and new red blood cell antibody formation.
Verduin EP; Schonewille H; Brand A; Haasnoot GW; Claas FH; Lindenburg IT; Lopriore E; Oepkes D; Roelen DL; Doxiadis II
Transfusion; 2013 May; 53(5):939-47. PubMed ID: 22924899
[TBL] [Abstract][Full Text] [Related]
3. Management and clinical consequences of red blood cell antibodies in pregnancy: A population-based cohort study.
Liu S; Ajne G; Wikman A; Lindqvist C; Reilly M; Tiblad E
Acta Obstet Gynecol Scand; 2021 Dec; 100(12):2216-2225. PubMed ID: 34476807
[TBL] [Abstract][Full Text] [Related]
4. [Haemolytic disease of the fetus and newborn/HDFN/timing in pregnant women and prophylaxis].
Kulinska R
Akush Ginekol (Sofiia); 2014; 53(2):58-63. PubMed ID: 25098112
[TBL] [Abstract][Full Text] [Related]
5. [Specificity and incidence of erythrocyte antibodies in pregnant patients with intrauterine transfusions for fetal erythroblastosis].
Hoch H; Giers G; Bald R; Hanfland P
Beitr Infusionsther; 1992; 30():439-42. PubMed ID: 1284755
[TBL] [Abstract][Full Text] [Related]
6. Long-Term follow up after intra-Uterine transfusionS; the LOTUS study.
Verduin EP; Lindenburg IT; Smits-Wintjens VE; van Klink JM; Schonewille H; van Kamp IL; Oepkes D; Walther FJ; Kanhai HH; Doxiadis II; Lopriore E; Brand A
BMC Pregnancy Childbirth; 2010 Dec; 10():77. PubMed ID: 21122095
[TBL] [Abstract][Full Text] [Related]
7. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
[TBL] [Abstract][Full Text] [Related]
8. Risk of maternal alloimmunization in Southern Pakistan - a study in a cohort of 1000 pregnant women.
Karim F; Moiz B; Kamran N
Transfus Apher Sci; 2015 Feb; 52(1):99-102. PubMed ID: 25532481
[TBL] [Abstract][Full Text] [Related]
9. High additional maternal red cell alloimmunization after Rhesus- and K-matched intrauterine intravascular transfusions for hemolytic disease of the fetus.
Schonewille H; Klumper FJ; van de Watering LM; Kanhai HH; Brand A
Am J Obstet Gynecol; 2007 Feb; 196(2):143.e1-6. PubMed ID: 17306657
[TBL] [Abstract][Full Text] [Related]
10. Successful management of severe red blood cell alloimmunization in pregnancy with a combination of therapeutic plasma exchange, intravenous immune globulin, and intrauterine transfusion.
Nwogu LC; Moise KJ; Klein KL; Tint H; Castillo B; Bai Y
Transfusion; 2018 Mar; 58(3):677-684. PubMed ID: 29250791
[TBL] [Abstract][Full Text] [Related]
11. [Management of feto-maternal red cell allo-immunizations].
Bricca P; Guinchard E; Guitton Bliem C
Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
[TBL] [Abstract][Full Text] [Related]
12. A correlation between severe haemolytic disease of the fetus and newborn and maternal ABO blood group.
Doyle B; Quigley J; Lambert M; Crumlish J; Walsh C; McParland P; Culliton M; Murphy K; Fitzgerald J
Transfus Med; 2014 Aug; 24(4):239-43. PubMed ID: 24975587
[TBL] [Abstract][Full Text] [Related]
13. [The importance of antenatal immunoprophylaxis for prevention of hemolytic disease of the fetus and newborn].
Starcević M; Mataija M; Sović D; Dodig J; Matijević R; Kukuruzović M
Acta Med Croatica; 2011 Mar; 65(1):49-54. PubMed ID: 21568074
[TBL] [Abstract][Full Text] [Related]
14. Successful management of severe hemolytic disease of the fetus due to anti-Jsb using intrauterine transfusions with serial maternal blood donations: a case report and a review of the literature.
Al Riyami AZ; Al Salmani M; Al Hashami S; Al Mahrooqi S; Al Hinai S; Al Balushi H; Al Riyami N; Gowri V; Al Dughaishi T; Al Hosni S; Al-Khabori M; Al-Farsi K; Al Huneini M; Alkindi S
Transfusion; 2014 Jan; 54(1):238-43. PubMed ID: 23829228
[TBL] [Abstract][Full Text] [Related]
15. Treatment of fetal anemia due to red-cell alloimmunization with intrauterine transfusions in the Netherlands, 1988-1999.
van Kamp IL; Klumper FJ; Meerman RH; Oepkes D; Scherjon SA; Kanhai HH
Acta Obstet Gynecol Scand; 2004 Aug; 83(8):731-7. PubMed ID: 15255845
[TBL] [Abstract][Full Text] [Related]
16. A descriptive single-centre experience of the management and outcome of maternal alloantibodies in pregnancy.
Chatziantoniou V; Heeney N; Maggs T; Rozette C; Fountain C; Watts T; Harrison C; Pasupathy D; Sankaran S; Kyle P; Robinson S
Transfus Med; 2017 Aug; 27(4):275-285. PubMed ID: 28608631
[TBL] [Abstract][Full Text] [Related]
17. Red Blood Cell Alloimmunization in the Pregnant Patient.
Webb J; Delaney M
Transfus Med Rev; 2018 Oct; 32(4):213-219. PubMed ID: 30097223
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of red-blood-cell and non-red-blood-cell-targeted autoantibodies in alloimmunized postpartum women.
Schonewille H; van de Watering LMG; Oepkes D; Lopriore E; Cobbaert CM; Brand A
Vox Sang; 2020 Nov; 115(8):783-789. PubMed ID: 32458481
[TBL] [Abstract][Full Text] [Related]
19. Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn.
Delaney M; Matthews DC
Hematology Am Soc Hematol Educ Program; 2015; 2015():146-51. PubMed ID: 26637714
[TBL] [Abstract][Full Text] [Related]
20. Antenatal maternal administration of phenobarbital for the prevention of exchange transfusion in neonates with hemolytic disease of the fetus and newborn.
Trevett TN; Dorman K; Lamvu G; Moise KJ
Am J Obstet Gynecol; 2005 Feb; 192(2):478-82. PubMed ID: 15695990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
